Publications by Deo Prakash Pandey

20 publications found

Publications 2025

  1. Pandey DP, Somyajit K (2025)
    Oncohistone-sculpted epigenetic mechanisms in pediatric brain cancer
    Curr Opin Pharmacol, 81, 102505
    DOI 10.1016/j.coph.2025.102505, PubMed 39874681
  2. Pop-Crisan A, Pirlog R, Pruteanu LL, Busuioc C, Pop OL, Pandey DP, Braicu C, Berindan-Neagoe I (2025)
    ATRX, OLIG2, MGMT, and IDH2 in Glioblastoma: Essential Molecular Mechanisms and Therapeutic Significance
    Medicina (Kaunas), 61 (4)
    DOI 10.3390/medicina61040697, PubMed 40282990

Publications 2024

  1. Lencioni G, Gregori A, Toledo B, Rebelo R, Immordino B, Amrutkar M, Xavier CPR, Kocijančič A, Pandey DP, Perán M, Castaño JP, Walsh N, Giovannetti E (2024)
    Unravelling the complexities of resistance mechanism in pancreatic cancer: Insights from in vitro and ex-vivo model systems
    Semin Cancer Biol, 106-107, 217-233
    DOI 10.1016/j.semcancer.2024.09.002, PubMed 39299411

Publications 2023

  1. Isachesku E, Braicu C, Pirlog R, Kocijancic A, Busuioc C, Pruteanu LL, Pandey DP, Berindan-Neagoe I (2023)
    The Role of Non-Coding RNAs in Epigenetic Dysregulation in Glioblastoma Development
    Int J Mol Sci, 24 (22)
    DOI 10.3390/ijms242216320, PubMed 38003512
  2. Lier S, Lund SO, Lipsa A, Frauenknecht KBM, Rein ID, Jain P, Lång AU, Lång EH, Meyer N, Datta A, Anand S, Nesse GJ, Forstrøm RJ, Klungland A, Rinholm JE, Bøe SO, Anands A, Pollard SM, Niclou SP, Lerdrup M, Pandey DP (2023)
    CDK12/CDK13 inhibition disrupts a transcriptional program critical for glioblastoma survival
    BioRxiv, 2023, 110-113
    DOI 10.1101/2023.07.14.548985v1, PublikaID 442

Publications 2022

  1. Hansen AM, Ge Y, Schuster MB, Pundhir S, Jakobsen JS, Kalvisa A, Tapia MC, Gordon S, Ambri F, Bagger FO, Pandey D, Helin K, Porse BT (2022)
    H3K9 dimethylation safeguards cancer cells against activation of the interferon pathway
    Sci Adv, 8 (11), eabf8627
    DOI 10.1126/sciadv.abf8627, PubMed 35302840

Publications 2021

  1. Sharma S, Mukherjee AK, Roy SS, Bagri S, Lier S, Verma M, Sengupta A, Kumar M, Nesse G, Pandey DP, Chowdhury S (2021)
    Human telomerase is directly regulated by non-telomeric TRF2-G-quadruplex interaction
    Cell Rep, 35 (7), 109154
    DOI 10.1016/j.celrep.2021.109154, PubMed 34010660

Publications 2019

  1. Segala G, Bennesch MA, Ghahhari NM, Pandey DP, Echeverria PC, Karch F, Maeda RK, Picard D (2019)
    Vps11 and Vps18 of Vps-C membrane traffic complexes are E3 ubiquitin ligases and fine-tune signalling
    Nat Commun, 10 (1), 1833
    DOI 10.1038/s41467-019-09800-y, PubMed 31015428

Publications 2018

  1. Bagger SO, Hopkinson BM, Pandey DP, Bak M, Brydholm AV, Villadsen R, Helin K, Rønnov-Jessen L, Petersen OW, Kim J (2018)
    Aggressiveness of non-EMT breast cancer cells relies on FBXO11 activity
    Mol Cancer, 17 (1), 171
    DOI 10.1186/s12943-018-0918-6, PubMed 30526604

Publications 2017

  1. Mohammad F, Weissmann S, Leblanc B, Pandey DP, Højfeldt JW, Comet I, Zheng C, Johansen JV, Rapin N, Porse BT, Tvardovskiy A, Jensen ON, Olaciregui NG, Lavarino C, Suñol M, de Torres C, Mora J, Carcaboso AM, Helin K (2017)
    EZH2 is a potential therapeutic target for H3K27M-mutant pediatric gliomas
    Nat Med, 23 (4), 483-492
    DOI 10.1038/nm.4293, PubMed 28263309

Publications 2016

  1. Segala G, Bennesch MA, Pandey DP, Hulo N, Picard D (2016)
    Monoubiquitination of Histone H2B Blocks Eviction of Histone Variant H2A.Z from Inducible Enhancers
    Mol Cell, 64 (2), 334-346
    DOI 10.1016/j.molcel.2016.08.034, PubMed 27692985

Publications 2013

  1. Malatesta M, Steinhauer C, Mohammad F, Pandey DP, Squatrito M, Helin K (2013)
    Histone acetyltransferase PCAF is required for Hedgehog-Gli-dependent transcription and cancer cell proliferation
    Cancer Res, 73 (20), 6323-33
    DOI 10.1158/0008-5472.CAN-12-4660, PubMed 23943798

Publications 2011

  1. Echeverría PC, Forafonov F, Pandey DP, Mühlebach G, Picard D (2011)
    Detection of changes in gene regulatory patterns, elicited by perturbations of the Hsp90 molecular chaperone complex, by visualizing multiple experiments with an animation
    BioData Min, 4 (1), 15
    DOI 10.1186/1756-0381-4-15, PubMed 21672238

Publications 2010

  1. Pandey DP, Picard D (2010)
    Multidirectional interplay between nuclear receptors and microRNAs
    Curr Opin Pharmacol, 10 (6), 637-42
    DOI 10.1016/j.coph.2010.08.009, PubMed 20829111

Publications 2009

  1. Pandey DP, Lappano R, Albanito L, Madeo A, Maggiolini M, Picard D (2009)
    Estrogenic GPR30 signalling induces proliferation and migration of breast cancer cells through CTGF
    EMBO J, 28 (5), 523-32
    DOI 10.1038/emboj.2008.304, PubMed 19153601
  2. Pandey DP, Picard D (2009)
    miR-22 inhibits estrogen signaling by directly targeting the estrogen receptor alpha mRNA
    Mol Cell Biol, 29 (13), 3783-90
    DOI 10.1128/MCB.01875-08, PubMed 19414598

Publications 2008

  1. Albanito L, Sisci D, Aquila S, Brunelli E, Vivacqua A, Madeo A, Lappano R, Pandey DP, Picard D, Mauro L, Andò S, Maggiolini M (2008)
    Epidermal growth factor induces G protein-coupled receptor 30 expression in estrogen receptor-negative breast cancer cells
    Endocrinology, 149 (8), 3799-808
    DOI 10.1210/en.2008-0117, PubMed 18467441
  2. Jørgensen MG, Pandey DP, Jaskolska M, Gerdes K (2008)
    HicA of Escherichia coli defines a novel family of translation-independent mRNA interferases in bacteria and archaea
    J Bacteriol, 191 (4), 1191-9
    DOI 10.1128/JB.01013-08, PubMed 19060138

Publications 2006

  1. Faridani OR, Nikravesh A, Pandey DP, Gerdes K, Good L (2006)
    Competitive inhibition of natural antisense Sok-RNA interactions activates Hok-mediated cell killing in Escherichia coli
    Nucleic Acids Res, 34 (20), 5915-22
    DOI 10.1093/nar/gkl750, PubMed 17065468

Publications 2005

  1. Pandey DP, Gerdes K (2005)
    Toxin-antitoxin loci are highly abundant in free-living but lost from host-associated prokaryotes
    Nucleic Acids Res, 33 (3), 966-76
    DOI 10.1093/nar/gki201, PubMed 15718296

 
Scroll to top